Insider profile

John T Treace

Treace Medical Concepts, Inc.director, 10 percent owner, officer: Chief Executive Officer

Backtest following this insider Back to feed

Insider Alpha Analytics

Average trade metrics summarize scored disclosures individually. Backtests simulate portfolio allocation over time.

30D 90D 180D 1Y 3Y

Trades Analyzed

3

Avg Trade Return

-4.4%

Avg Trade Alpha

-4.5%

Win Rate

33%

Avg Holding Days

5

Insider Performance

Equal-weight scored trade outcomes, not portfolio CAGR.

Performance Curve Company Stock

Return Alpha

InsiderS&P 500

Equal-Weight Outcome Return

Best Trades

TMCI

Jun 1, 2026 · purchase

3.7%

Return

6.1%

Alpha

Worst Trades

TMCI

Jun 11, 2026 · purchase

-8.7%

Return

-9.1%

Alpha

Top tickers

TMCI

5 trades

Top tickers

Recent trades

Displayed quotes are USD. Current foreign prices use spot FX where applicable; historical foreign filing prices use trade-date FX and ADR ratios when normalized. Original reported prices remain shown below.

TMCI

Treace Medical Concepts, Inc.

Trade date

Jun 11, 2026

Side

Purchase

Price

$4

Trade value

$39,982

PnL

▼ 8.7%

Signal

28

TMCI

Treace Medical Concepts, Inc.

Trade date

Jun 10, 2026

Side

Purchase

Price

$4

Trade value

$59,213

PnL

▼ 8.3%

Signal

28

TMCI

Treace Medical Concepts, Inc.

Trade date

Jun 01, 2026

Side

Purchase

Price

$4

Trade value

$177,915

PnL

▲ 3.7%

Signal

29

TMCI

Treace Medical Concepts, Inc.

Trade date

Mar 10, 2026

Side

F-Inkind

Price

—

Trade value

—

PnL

▲ 174.3%

Signal

7

TMCI

Treace Medical Concepts, Inc.

Trade date

Mar 08, 2026

Side

F-Inkind

Price

—

Trade value

—

PnL

—

Signal

No signal

Top tickers

TMCI

5 trades